Offer - Urjas Oil for just ₹ 1 X
Rozustat F is a prescription medicine that is available as a Tablet. Other than this, Rozustat F has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Rozustat F. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The side effects typically associated with Rozustat F include Nausea or vomiting, Headache, Constipation. Some other side effects of Rozustat F have been listed ahead. Usually, these side effects of Rozustat F go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Rozustat F's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Rozustat F's effects on the liver, heart and kidney are discussed below in the Rozustat F related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Rozustat F since this can cause severe adverse effects.
Drug reaction of Rozustat F with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Rozustat F is not safe while driving, and is not addiction.
Rozustat F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rozustat F safe for pregnant women?
Pregnant women may experience moderate side effects from Rozustat F. It is best to stop taking Rozustat F immediately and inform your doctor if you notice any discomfort.
Is the use of Rozustat F safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Rozustat F. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Rozustat F on the Kidneys?
Rozustat F rarely affects the kidneys.
What is the effect of Rozustat F on the Liver?
Rozustat F is rarely harmful for the liver.
What is the effect of Rozustat F on the Heart?
The heart can be affected by Rozustat F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Rozustat F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rozustat F unless your doctor advises you to do so -
Is this Rozustat F habit forming or addictive?
No, there is no any evidence that Rozustat F is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rozustat F, you should not drive or work on any heavy machine, as Rozustat F can make you drowsy.
Is it safe?
Rozustat F is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Rozustat F in mental disorders is not effective.
Interaction between Food and Rozustat F
Due to the absence of research, it is difficult to say how Rozustat F and food will interact.
Interaction between Alcohol and Rozustat F
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rozustat F.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650